#ESMO26 Very thoughtful and balanced discussion of VOLGA trial by @MichvdHeijden , putting EV-D in perspective with EV-303/B15 on efficacy & safety.
Adding treme = more tox, no efficacy/OS gain.
Less is more!
Takeaway for next steps:
response-adapted adjuvant therapy?

@myESMO @tompowles1 @brian_rini @Uromigos